Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Target Healthcare REIT's 10-Year RORE % for the quarter that ended in Dec. 2025 was 46.10%.
The industry rank for Target Healthcare REIT's 10-Year RORE % or its related term are showing as below:
LSE:THRL's 10-Year RORE % is ranked better than 80.12% of 493
companies
in the REITs industry
Industry Median: 9
vs LSE:THRL: 46.10
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Target Healthcare REIT 10-Year RORE % Related Terms
Target Healthcare REIT 10-Year RORE % Historical Data
* Premium members only.
The historical data trend for Target Healthcare REIT's 10-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:THRL vs WELL, VTR, DOC: 10-Year RORE % Comparison
For the REIT - Healthcare Facilities subindustry, Target Healthcare REIT's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Target Healthcare REIT 10-Year RORE % vs REITs Industry
For the REITs industry and Real Estate sector, Target Healthcare REIT's 10-Year RORE % distribution charts can be found below:
* The bar in red indicates where Target Healthcare REIT's 10-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2025 and 10-year before.
Target Healthcare REIT (LSE:THRL) has a 10-Year RORE % of 46.10 as of Dec. 2025. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on Target Healthcare REIT and its competitors. According to the industry distribution chart, Target Healthcare REIT ranks #98 out of 493 companies in the REITs industry, placing it in the top 19.9%.
Is Target Healthcare REIT's 10-Year RORE % too high?
Target Healthcare REIT's current 10-Year RORE % is 46.10. The REITs industry median 10-Year RORE % is 9.00. Target Healthcare REIT's value of 46.10 is 412.2% above this industry median. Based on the distribution chart, Target Healthcare REIT ranks #98 out of 493 companies in the REITs industry, which is in the top quartile — a strong position relative to peers. Overall, Target Healthcare REIT has a GF Score™ of 40/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Target Healthcare REIT's 10-Year RORE % compare to WELL and VTR?
According to the REITs industry distribution chart, Target Healthcare REIT ranks #98 out of 493 companies for 10-Year RORE %. This places Target Healthcare REIT in the top 20% of its industry — outperforming the majority of peers. The industry median 10-Year RORE % is 9.00. Target Healthcare REIT's value of 46.10 is 412.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year RORE % for a REITs company?
The median 10-Year RORE % among REITs companies is 9.00, based on 493 companies in the industry. Companies in the top quartile (top 25%) have a 10-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 10-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Target Healthcare REIT's current 10-Year RORE % of 46.10 is 412.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year RORE % mean?
A high 10-Year RORE % can signal that a stock is expensive relative to its fundamentals. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on Target Healthcare REIT and its competitors. For the REITs industry, the median 10-Year RORE % is 9.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Target Healthcare REIT's current 10-Year RORE % is 46.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Target Healthcare REIT stock overvalued right now?
Based on GuruFocus' analysis, Target Healthcare REIT (LSE:THRL) is currently considered Modestly Overvalued. The stock's GF Value™ is £0.88, compared to a current price of £1.11 — trading 26.4% above its estimated fair value. The current 10-Year RORE % is 46.10 and 412.2% above the REITs industry median of 9.00. Target Healthcare REIT's overall GF Score™ is 40/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year RORE % calculated?
10-Year RORE % is calculated from a company's financial statements. For Target Healthcare REIT (LSE:THRL), the current 10-Year RORE % is 46.10 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Target Healthcare REIT (LSE:THRL) Overvalued in 2026?
Based on GuruFocus' analysis, Target Healthcare REIT stock appears to be overvalued.
The current stock price of £1.11 is trading 26.4% above its estimated GF Value™ of £0.88.
GuruFocus considers Target Healthcare REIT to be Modestly Overvalued.
Key valuation signals for LSE:THRL:
10-Year RORE %: 46.10
GF Value™: £0.88 vs. price of £1.11 (26.4% above fair value)
Industry Position: 412.2% above the REITs median (#98 of 493)
No single metric tells the full story. See the LSE:THRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Target Healthcare REIT PLC is an investment company that acts as a long-term investor in care homes in the United Kingdom. The investment objective of the company is to provide shareholders with an attractive level of income together with the potential for capital and income growth from investing in a diversified portfolio of freehold and long-leasehold care homes, which are let to care home operators, and other healthcare assets in the United Kingdom.
40GF Score
Get the complete analysis for LSE:THRL
10-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:THRL has been successfully added to your 
